Monday, October 3, 2016

Sexual function was no worse when fewer external beam radiation treatments were used



The HYPRO trial was designed to detect whether hypofractionation (fewer radiation treatments) was inferior to conventional fractionation. Their previous report looked at outcomes on late-term urinary and rectal function. Here, they report on sexual function outcomes.

To briefly recap, 820 intermediate/high risk patients were randomly assigned to one of two external beam radiation treatment protocols:
  • Conventional fractionation: 78 Gy in 39 treatments
  • Hypofractionation: 64.6 Gy in 19 treatments
  • 39% had adjuvant hormone therapy lasting up to 6 months

It should also be noted that men were 71 years of age at the time of treatment.

After median follow-up of 37 months:
  • Among those with partial or full erectile function at baseline, erectile dysfunction occurred in 34.4% among those who had hypofractionation and 39.3% among those who had conventional fractionation. The difference was not statistically significant.
  • Orgasmic function among those who did not have hormone therapy was higher for the hypofractionation group. The difference was statistically significant.
  • Overall, sexual function scores declined after treatment, but there was no difference between two treatments.

Two other randomized clinical trials also reported no difference in sexual function. Both the Fox Chase trial (see this link) and the M.D. Anderson trial (see this link) found hypofractionation made no difference in sexual outcomes. This should give some comfort to patients and radiation oncologists considering hypofractionation.

No comments:

Post a Comment